Effects of pravastatin on exercise electrocardiography test performance and cardiovascular mortality and morbidity in patients with hypercholesterolemia: Lipid intervention study in Kyoto

Circulation Journal

Volumn 66, Issue 1, 2002, Pages 47-52

  Susumu, Sasaki ^a   Masao, Nakagawa ^a   Tetsuo, Nakata ^b   Akihiro, Azuma ^a   Shohei, Sawada ^a   Kazuo, Takeda ^a   Jun, Asayama ^b  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

3 hydroxy 3 methyl glutaryl coenzyme A (HMG CoA) reductase inhibitor; Cholesterol; Coronary heart disease; Exercise electrocardiography test; Pravastatin

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL; FIBRIC ACID DERIVATIVE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NICOTINIC ACID; PRAVASTATIN; PROBUCOL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; EXERCISE ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; HYPERCHOLESTEROLEMIA; ISCHEMIC HEART DISEASE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SIDE EFFECT; STROKE; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; ANTICHOLESTEREMIC AGENTS; APOLIPOPROTEINS; BODY CONSTITUTION; CARDIOVASCULAR DISEASES; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; ELECTROCARDIOGRAPHY; EXERCISE TEST; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; JAPAN; MALE; MIDDLE AGED; MORBIDITY; PRAVASTATIN; PREDICTIVE VALUE OF TESTS; TIME FACTORS; TRIGLYCERIDES;

EID: 0036242346     PISSN: 13469843     EISSN: None     Source Type: Journal    
DOI: 10.1253/circj.66.47     Document Type: Article

References (21)

1. Serum cholesterol, lipoproteins and the risk of coronary heart disease. The Framingham study
2. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial
3. A co-operative trial in the primary prevention of ischemic heart disease using clofibrate. Report from the Committee of Principal Investigators
4. The Lipid Research Clinics Coronary Primary Prevention Trial Results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering
5. Helsinki heart study: Primary prevention trial with gemfibrozil in middle-aged men with dyslipidemia
6. Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC 1): Reduction in atherosclerosis progression and clinical events
7. Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol level
8. The effect of pravastatin on coronary events after myocardial infarction inpatients with average cholesterol level
9. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
10. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
11. A brief review of epidemiological studies on ischemic heart disease in Japan
12. Changes in cardiovascular disease risk factors in three Japanese national surveys 1971-1990
13. The 'two-step' exercise test brought up to date
14. Regression models and life-tables
15. Sudden death in the general population in Okinawa; Incidence and causes of death
16. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly
17. Lipid lowering and plaque regression: New insights into prevention of plaque disruption and clinical events in coronary disease
18. Pathogenesis of atherosclerosis
19. Postexercise electrocardiography: Correlations with coronary arteriography and left ventricular hemodynamics
20. Significant sex differences in the correlation of electrocardiographic exercise testing and coronary arteriogram